PREGNANCY OUTCOMES IN WOMEN WITH HISTORY OF COVID-19 | ||||
| ALEXMED ePosters | ||||
| Article 1, Volume 5, Issue 2, April 2023, Page 14-15 | ||||
| Document Type: Preliminary preprint short reports of original research | ||||
| DOI: 10.21608/alexpo.2023.209939.1608 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Nermeen Saad El-Beltagy1; Helm Abelsater2; Mohamed Hamdy Basiony Darweesh  3
| ||||
| 1Department of Obstetrics and Gynecology, Alexandria Faculty of Medicine, Alexandria University | ||||
| 2Department of Obstetrics and Gynecology, Faculty of Medicine, University of Alexandria | ||||
| 3Department of Obstetrics and Gynecology, Faculty of Medicine - University of Alexandria | ||||
| Abstract | ||||
| With its initial appearance in Wuhan, China, in December 2019, the coronavirus disease-related respiratory infection (COVID-19) has rapidly spread among people all over the world. Due of its detrimental effects on global health, the World Health Organization (WHO) considered this disease to be a pandemic in March 2020. The severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks have proved that pregnant females as well as their fetuses are exposed to adverse outcomes, including high rates of intensive care unit (ICU) admission and case fatality. Physiological changes occurring during pregnancy such as the increased transverse diameter of the thoracic cage as well as the elevation of the diaphragm can expose the mother to severe infections because of her decreased tolerance for hypoxia. Furthermore, vasodilation and changes in lung capacity can cause mucosal edema and an increase in upper respiratory tract secretions. In addition, the increased susceptibility to infection is enhanced by changes in cell-mediated immunity. | ||||
| Keywords | ||||
| COVID-19; PREGNANCY; OUTCOMES | ||||
|
Supplementary Files
|
||||
|
Statistics Article View: 31 |
||||
